Applied Biosciences· 2026Q1· Review
Neurotransmitter Systems and Systemic Resilience in the Healthy Aging Brain
- 0citations
- Q1SCImago
- 2026year
Short summary
Neurotransmitter systems integrate central resilience and peripheral signaling to drive healthy brain aging, interacting with cellular resilience regulators like SIRT1/Klotho/mTORC1 and epigenetic clocks (N6medA).
AI-generated from the title and abstract; the full text is not read.
Key points
- Neurotransmitter systems are central to integrating brain resilience and systemic signaling in healthy aging.
- Key regulators of cellular resilience, including SIRT1/Klotho/mTORC1 and the N6medA epigenetic clock, interact with neurochemical changes.
- Multi-organ axes (muscle–gut–liver–brain) and environmental exposures (childhood poverty, air pollution) influence aging trajectories.
- Advanced techniques like multimodal neuroimaging and AI-based brain-age estimation are crucial for biomarker discovery.
AI-generated from the title and abstract; the full text is not read.
Abstract
Physiological brain aging is driven by progressive neuro-glial-vascular remodeling, in which neurotransmitter systems serve as the core functional network integrating central resilience and peripheral systemic signaling. This narrative review provides a comprehensive synthesis of the molecular, cellular, and circuit-level mechanisms underlying healthy brain aging. Centered on classical and modulatory neurotransmitter systems, we examine how neurochemical trajectories interact with key regulators of cellular resilience, including the SIRT1/Klotho/mTORC1 signaling network, epigenetic modifications such as the N(6)-methyldeoxyadenosine (N6medA) clock, extracellular matrix dynamics, and multi-organ (muscle–gut–liver–brain) axes. We also discuss how socioeconomic and environmental exposures, such as childhood poverty and air pollution, contribute to individual aging trajectories throughout life. Recent advances in multimodal neuroimaging, spatial transcriptomics (IRISeq), and AI-based brain-age estimation (e.g., ResNet-CrossViT) are highlighted as promising approaches for identifying biomarkers capable of distinguishing physiological aging from the earliest stages of neurodegeneration. Collectively, healthy brain aging represents a dynamic process of biological adaptation in which neurotransmitter remodeling, cellular resilience, metabolic homeostasis, and systemic interactions jointly determine cognitive outcomes. Understanding these interconnected mechanisms provides a framework for developing preventive strategies aimed at preserving cognitive function and extending brain health span.
The authors' abstract, as published at the source. Applied Biosciences, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
AgingBiochemistry, Genetics and Molecular Biology